Context: Breast cancer is a complex disease with heterogeneous prognosis. The selection of systemic adjuvant chemotherapy is based on prognostic and predictive factors. The hormone receptor levels are good predictive markers of response to hormone therapy; but their prognostic value is still debated. Objective: The present study was undertaken to observe the trend and to analyze the status of hormone receptor expression in breast carcinoma at our institute, and to assess their value in terms of established prognostic markers, viz: tumor size, tumor grade, tumor necrosis, lymphovascular invasion, Cerb-B2 overexpression and lymph node metastasis status. Design: We analyzed 222 cases breast carcinomas reported at our institute from Jan 2002 to...
Purpose: Limited evidence exists on the impact of hormone receptor (HR) status to counsel HER2-posit...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
PURPOSE: Trastuzumab-based treatment is the standard care for patients with HER2+ metastatic breast ...
 ABSTRACT:Objective:Breast cancer comprises different biological subtypes having varied spectrum of...
It was 40 years ago, that the importance of steroid hormone receptors in the biology of breast cance...
Objectives: Hormone-receptor (HR) and HER2/neu-receptor (HER2) status of breast tumors are important...
Objective: The purpose of this study was to evaluate the impact of various pathologic and biologic f...
Purpose: Androgen receptor (AR) expression has been observed in about 70% of patients with breast ca...
Abstract- Background: Prognostic factors of breast cancer not only act as a guide to overall prognos...
International audienceBackground: The purpose of this study was to determine the prognostic role of ...
Purpose: Estrogen receptor status in breast cancer is associated with response to hormonal therapy ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
INTRODUCTION: The approach to the management of breast carcinoma has undergone enormous changes ove...
PURPOSE: To evaluate prognostic factors in estrogen receptor (ER)-positive, operable breast cancer f...
Tumor-associated macrophages (TAMs) are involved in tumor progression by promoting epithelial-mesenc...
Purpose: Limited evidence exists on the impact of hormone receptor (HR) status to counsel HER2-posit...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
PURPOSE: Trastuzumab-based treatment is the standard care for patients with HER2+ metastatic breast ...
 ABSTRACT:Objective:Breast cancer comprises different biological subtypes having varied spectrum of...
It was 40 years ago, that the importance of steroid hormone receptors in the biology of breast cance...
Objectives: Hormone-receptor (HR) and HER2/neu-receptor (HER2) status of breast tumors are important...
Objective: The purpose of this study was to evaluate the impact of various pathologic and biologic f...
Purpose: Androgen receptor (AR) expression has been observed in about 70% of patients with breast ca...
Abstract- Background: Prognostic factors of breast cancer not only act as a guide to overall prognos...
International audienceBackground: The purpose of this study was to determine the prognostic role of ...
Purpose: Estrogen receptor status in breast cancer is associated with response to hormonal therapy ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
INTRODUCTION: The approach to the management of breast carcinoma has undergone enormous changes ove...
PURPOSE: To evaluate prognostic factors in estrogen receptor (ER)-positive, operable breast cancer f...
Tumor-associated macrophages (TAMs) are involved in tumor progression by promoting epithelial-mesenc...
Purpose: Limited evidence exists on the impact of hormone receptor (HR) status to counsel HER2-posit...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
PURPOSE: Trastuzumab-based treatment is the standard care for patients with HER2+ metastatic breast ...